Alfonso Galderisi
APHP · University Hospital of Padua
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alfonso Galderisi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:40 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07880769 · Verapamil In Preclinical Type 1 DiabetesAssistance Publique - Hôpitaux de Paris · not yet recruiting · Type 1 Diabetes · study chair
- N/ANCT04347590 · Continuous Glucose Monitoring and Cerebral Oxygenation in Preterm InfantsUniversity Hospital Padova · unknown · Infant Development, Hypoglycemia Neonatal, Neurodevelopmental Abnormality · principal investigator
- Ph4NCT02583776 · Continuous Glucose Monitoring and Preterm InfantsUniversity Hospital Padova · completed · Infant, Very Low Birth Weight, Neonatal Hypoglycemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:40 UTC. The ranking covers the 200 most relevant of 16 PubMed records, and a shared surname and initials can bring in a namesake. All 16 on PubMed
- Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.Circulation · 201993 citationsRCR 3.9
- Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial.Pediatrics · 201781 citationsRCR 4.3
- Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe.Diabetes Care · 201675 citationsRCR 3.4
- Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.Diabetes Technol Ther · 202066 citationsRCR 3.9
- Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism.J Clin Endocrinol Metab · 201929 citationsRCR 1.5
- Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting.Diabetes Care · 201627 citationsRCR 1.2
- Effect of Afrezza on Glucose Dynamics During HCL Treatment.Diabetes Care · 202022 citationsRCR 1.0
- Inhibition of 11β-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study.Diabetes Obes Metab · 202221 citationsRCR 1.9
- Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.J Clin Endocrinol Metab · 201820 citationsRCR 0.8
- Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.Diabetologia · 202516 citationsRCR 4.3